Skip to main content
See every side of every news story
Published • loading... • Updated

Duchenne Musculoskeletal Dystrophy: First CRISPR Gene Therapy in Humans Shows Limited Effect

Shanghai – An experimental CRISPR-based gene therapy in a first clinical study in boys with duchenne musculoskeletal dystrophy (DMD) partially restored the production of muscle protein dystrophin. However, the effect remained low. One of the 4 boys treated had a severe immune response with fatal outcome...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Shanghai – An experimental CRISPR-based gene therapy in a first clinical study in boys with duchenne musculoskeletal dystrophy (DMD) partially restored the production of muscle protein dystrophin. However, the effect remained low. One of the 4 boys treated had a severe immune response with fatal outcome...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Deutsches Ärzteblatt broke the news on Wednesday, November 11, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal